Dr. Wiplove Lamba & Jean-Paul Michael
Dr. Wiplove Lamba & Jean-Paul Michael
#160 NITAZENE ALERT: The Emerging Threat of an Ultra-Potent Opioid
#160 NITAZENE ALERT: The Emerging Threat of an Ultra-Potent Opioid
#160 NITAZENE ALERT: The Emerging Threat of an Ultra-Potent Opioid
Tuesday 25th February 2025
Explore the rise of Nitazene, a potent synthetic opioid, and its impact on the opioid crisis. Learn about harm reduction strategies and public health responses.
10 minutes
Informative
Compassionate
Hopeful
Educational
Supportive
About this podcast
Author:
Dr. Wiplove Lamba & Jean-Paul Michael
Overview:
Categories:
Understanding Addiction & Recovery
Sobriety Toolkit
Navigating Intimate Relationships
Family Recovery from Addiction
Creative Recovery Journeys
Links:
Visit site
Episodes:
66 (View all)
Do you want to link to this podcast?
Get the buttons here!Nitazene: The New Shadow in the Opioid Crisis
Episode Overview
- Nitazene is significantly more potent than fentanyl.
- It was developed in the 1950s but never approved for medical use.
- Nitazene has resurfaced in the illicit drug market.
- It is often found in dangerous mixtures with other substances.
- Vigilant monitoring and informed responses are essential.
Nitazene is reshaping the landscape of our fight against the opioid epidemic, introducing new complexities to the strategies we need to deploy
In this episode of Captain Hooked: The Addiction Project, addiction psychiatrist Dr. Wiplove (Wip) Lamba and addictions case manager Jean-Paul (JP) Michael tackle the alarming rise of Nitazene, a synthetic opioid significantly more potent than fentanyl. With their expertise, they delve into the historical background of Nitazene, its current impact, and the challenges it poses in North America.
This episode highlights the drug's interaction with other substances, its role in increasing opioid overdose rates, and essential harm reduction strategies needed to combat this growing threat. Nitazene, originally developed by Swiss researchers in the 1950s, was never approved for medical use due to its extreme potency and associated risks. Despite this, it has resurfaced in the illicit drug market, often found in dangerous mixtures with other substances.
The hosts discuss the urgent need for vigilant monitoring of the drug supply and informed responses to the challenges posed by Nitazene. They also emphasize the importance of public health awareness and action to mitigate its impact on community safety. This episode is a wake-up call to the resilience and adaptability required in our healthcare system to confront this new shadow in the opioid crisis.
Tune in to gain a deeper understanding of Nitazene and learn how we can collectively address this formidable foe.